Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Liothyronine 50micrograms/5ml oral liquid
0602010M0AAALAL
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 5micrograms/5ml oral liquid
0602010M0AAANAN
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liparol 400 XL tablets
0212000D0BDAAAB
|
Liparol | Bezafibrate | Cardiovascular System | No data available |
|
Lipegfilgrastim 6mg/0.6ml inj pre-filled syringes
0901060Q0AAAAAA
|
Lipegfilgrastim | Lipegfilgrastim | Nutrition and Blood | No data available |
|
Lipobay 100microgram tablets
0212000C0BBAAAA
|
Lipobay | Cerivastatin | Cardiovascular System | No data available |
|
Lipobay 200microgram tablets
0212000C0BBABAB
|
Lipobay | Cerivastatin | Cardiovascular System | No data available |
|
Lipobay 300microgram tablets
0212000C0BBACAC
|
Lipobay | Cerivastatin | Cardiovascular System | No data available |
|
Lipobay 400microgram tablets
0212000C0BBADAD
|
Lipobay | Cerivastatin | Cardiovascular System | No data available |
|
Lipobay 800microgram tablets
0212000C0BBAEAE
|
Lipobay | Cerivastatin | Cardiovascular System | No data available |
|
Liposic 0.2% eye gel
1108010B0BDABAB
|
Liposic | Carbomer 940/980 | Eye | No data available |
|
LipoSil Liposomal D3 2,000unit capsules
0906040G0EVAABA
|
LipoSil Liposomal D3 | Colecalciferol | Nutrition and Blood | No data available |
|
LipoSil Liposomal Iron 15mg and Active folate 173.88microg
0901011Q0BRAAAP
|
LipoSil Liposomal | Iron and folic acid | Nutrition and Blood | No data available |
|
LipoSil Liposomal Vitamin C 400mg capsules
090603300BCAAAB
|
LipoSil | Other vitamin C preparations | Nutrition and Blood | No data available |
|
LipoSil Liposomal Vitamin C 500mg capsules
0906031C0CNAABI
|
LipoSil Liposomal Vitamin C | Ascorbic acid | Nutrition and Blood | No data available |
|
LipoSil Liposomal Vitamin D3 1,000unit + K2 45microgram caps
090607000BBMFBQ
|
Proprietary compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | No data available |
|
LipoSil Liposomal Vitamin D3 1,000unit tablets
0906040G0FBAABG
|
LipoSil Liposomal Vitamin D3 | Colecalciferol | Nutrition and Blood | No data available |
|
Lipostat 10mg tablets
0212000X0BBAAAA
|
Lipostat | Pravastatin sodium | Cardiovascular System | No data available |
|
Lipostat 20mg tablets
0212000X0BBABAB
|
Lipostat | Pravastatin sodium | Cardiovascular System | No data available |
|
Lipostat 40mg tablets
0212000X0BBACAD
|
Lipostat | Pravastatin sodium | Cardiovascular System | No data available |
|
Liq paraffin / Magnesium hydroxide emulsn sugar free
0106040J0AAAFAF
|
Magnesium hydroxide (Laxative) | Magnesium hydroxide | Gastro-Intestinal System | No data available |
|
Liq paraffin light 46% / Isopropyl myristate 39% bath emol
1302011L0AAACAC
|
Light liquid paraffin | Light liquid paraffin | Skin | No data available |
|
Liqua Care FlowGel diabetic orthotic insoles size 35-36
21290000126
|
Liqua Care FlowGel diabetic orthotic insoles size 35-36 | Pressure Offloading Device | Appliances | No data available |
|
Liqua Care FlowGel diabetic orthotic insoles size 39-40
21290000128
|
Liqua Care FlowGel diabetic orthotic insoles size 39-40 | Pressure Offloading Device | Appliances | No data available |
|
Liqufruta Garlic Cough Medicine 50mg/5ml oral solution
0309020G0BWAAAL
|
Liqufruta | Guaifenesin | Respiratory System | No data available |
|
Liquick Plus catheter female 10Ch
21020001213
|
Liquick Plus catheter female 10Ch | Catheters | Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.